Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Non-cash Items (2016 - 2025)

Historic Non-cash Items for CorMedix (CRMD) over the last 11 years, with Q3 2025 value amounting to $3.3 million.

  • CorMedix's Non-cash Items fell 5582.33% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 5582.33%. This contributed to the annual value of $23.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CorMedix's Non-cash Items is $3.3 million, which was down 5582.33% from $2.4 million recorded in Q2 2025.
  • CorMedix's Non-cash Items' 5-year high stood at $23.6 million during Q4 2024, with a 5-year trough of $337075.0 in Q4 2021.
  • Its 5-year average for Non-cash Items is $6.8 million, with a median of $7.5 million in 2024.
  • Per our database at Business Quant, CorMedix's Non-cash Items soared by 50238.7% in 2021 and then plummeted by 9419.62% in 2025.
  • Quarter analysis of 5 years shows CorMedix's Non-cash Items stood at $337075.0 in 2021, then soared by 230.21% to $1.1 million in 2022, then surged by 483.98% to $6.5 million in 2023, then soared by 262.58% to $23.6 million in 2024, then tumbled by 86.0% to $3.3 million in 2025.
  • Its Non-cash Items was $3.3 million in Q3 2025, compared to $2.4 million in Q2 2025 and $530000.0 in Q1 2025.